Filter by Category:
INFORMATION
DAY 3
Chaired by: Dr Pranab Haldar (Leicester)
INFORMATION
DAY 3
Chaired by: Professor Liam Heaney (Belfast) and Dr Maisha Jabeen (Oxford)
9:00am - Overcrowding in the asthmatic airway: the consequences of bronchospasm
Professor Jody Rosenblatt (London)
9:30am - Greater than the sum of their parts: mast cell – eosinophil interactions in asthma
Professor Sven-Erik Dahlén (Sweden)
10:00am - Upside down: epithelial responses to eosinophil targeting
Dr Hitasha Rupani (Southampton)
INFORMATION
DAY 3
Chaired by: Dr Katie Ward (London) and Dr Rahul Mahida (Birmingham)
9:00am - Mechanisms of autoimmunity in ILD
Professor Joanna Porter (London
9:30am - Navigating the spectrum of vasculitis in ILD
Professor David Jayne (Cambridge)
10:00am - Phenotyping the myositis patient and tailoring management to specific subtypes
Dr Harsha Gunawardena (Bristol)
INFORMATION
DAY 3
Chaired by: Professor Robert Gray (Glasgow) and Dr Dawn Lau (Cardiff)
9:00am - Covering changing microbial ecology and potential new approaches such as phage therapy
Professor Jo Fothergil (Liverpool)
9:30am - What can we learn from large animal models of CF and non-CF Bronchiectasis?
Professor David Stoltz (USA)
10:00am - Exploring how understanding non-pathogen driven autoinflammation may be the key to treating residual inflammation in the CF lung following CFTR modulator therapy
Professor Daniel Peckham (Leeds)
INFORMATION
DAY 3
Chaired by: Professor Gary Lee (Perth) and Dr Selina Tsim (Glasgow)
10:45am - Genetic mechanisms in pneumothorax and cystic lung diseases
Professor Stefan Marciniak (Cambridge)
11:15am - Macrophage subtypes and cellular immunity in pleural infection
Professor Laura Gleeson (Dublin)
11:45am - Pleural septation detection, formation and biology – insights from early phase studies
Dr Eihab Bedawi (Oxford)
INFORMATION
DAY 3
Chaired by: Dr Vicky Moore (Coventry) and Professor Luke Howard (London)
10:45am - Specialist nursing: physiological data within severe asthma, the path to therapeutics
Katie Borg (Oxford)
11:15am - Physiotherapy: physiological data for dysfunctional breathing, a growing evidence base
Chelliah Paramasivan (Cambridge)
11:45am - Physician clinics: physiology data in pulmonary vascular disease, what’s new?
Dr Martin Johnson (Scotland)
INFORMATION
DAY 3
Chaired by: Dr Andy Molyneux (Mansfield)
10:45am - New assessment pathways for patients attending hospital with exacerbations of COPD or asthma
Dr James Dodd (Bristol)
11:15am - Findings from analysis of oxygen safety incidents related to type 2 acute respiratory failure
Dr Hamish Duff (Bristol)
11:45am - National Confidential Enquiry into Patient Outcome and Death (NCEPOD) report on pleural procedures
Dr Mark Juniper (Swindon)
INFORMATION
DAY 3
INFORMATION
DAY 3
Chaired by: Dr Sonya Craig (Liverpool) and Helen May (Manchester)
1:45pm - Gender differences in obstructive sleep apnoea
Dr Renata Riha (Scotland)
2:15pm - MAD plus CPAP: does combining two established treatments for obstructive sleep apnoea give added benefits?
Dr Tim Quinnell (Cambridge
2:45pm - Complex sleep apnoea and ASV: evidence, controversies, and patient selection
Professor Esther Schwarz (Zurich)
INFORMATION
DAY 3
Chaired by: Dr Frances Grudzinska (Nottingham) and Dr Meg Coleman (London)
1:45pm - Host immune responses and corticosteroid effects in severe CAP
Professor Thomas Wilkinson (Southampton)
2:15pm - Effect of steroids on mortality in patients with severe community-acquired pneumonia: The REMAP-CAP Corticosteroid Domain Randomised Clinical Trial in context
Professor Anthony Gordon (London)
2:45pm - NICE guidelines in context – steroids in pneumonia
Dr Tom Bewick (Derby)
INFORMATION
DAY 3
Chaired by: Professor David Lomas (London) and Dr Samantha Walker (ALUK)
1:45pm - New and known pathological pathways as novel targets during the early phases of chronic respiratory disease
Dr Renata Jurkowska (Cardiff)
2:15pm - Preventing acute microbial-driven exacerbations from destabilising lung function and worsening chronic disease
Dr Aurelie Crabbe (Belgium)
2:45pm - Opportunities for targeting common cross-disease mechanisms to prevent progression of chronic lung diseases
Dr Amanda Tatler (Nottingham)
INFORMATION
DAY 3
Chaired by: Dr Liz Fuller (Newcastle) and Dr Alexandra Teagle (Plymouth)
3:30pm - Expanding roles of liquid biopsies for lung cancer: detection, residual disease, surveillance and beyond
Professor Nitzan Rosenfeld (London)
4:00pm - Second primary lung cancers – who is at risk and how long should we follow people up?
Professor Robert Rintoul (Cambridge)
4:30pm - LungVax: early interception and prevention in the lung cancer setting
Professor Mariam Jamal-Hanjani (London)
INFORMATION
DAY 3
Chaired by: Professor Alice Turner (Birmingham) and Dr Hannah Burke (Southampton)
3:30pm - Patient centred innovation – overcoming health inequalities
Professor Ian Sinha (Liverpool)
3:50pm - Respiratory innovation and improvement in primary care
Dr Katherine Hickman (Leeds)
4:10pm - Driving impact from new therapies
Professor James Dodd (Bristol) and Dr Irem Patel (London)
4:30pm - Understanding new models of care
Professor Alice Turner (Birmingham)